- Vancouver Tech Journal
- Posts
- 17 ventures set to take the stage at UBC’s 2025 Investor Showcase
17 ventures set to take the stage at UBC’s 2025 Investor Showcase
Meet Vancouver’s next wave of innovators.

A new class of ambitious ventures is ready to make their mark.
At this year’s UBC Innovation Investor Showcase, a group of bold, science- and technology-driven startups will present breakthroughs spanning biotechnology, clean tech, advanced manufacturing, and AI.
Here’s a look at the teams stepping into the spotlight:
Baerfell
Developing plant-based insulation for sustainable apparel, outdoor gear, and packaging.
Binta Financial
Driving global financial inclusion by enabling seamless credit mobility for newcomers.
Bayes Studio
AI-driven wildfire prediction, detection, and long-range monitoring for safer communities.
CereCura Nanotherapeutics
Developing transformative nanomedicine to treat brain diseases.
eSense Health
Clinically-proven digital therapy to improve women’s sexual health.
ImageCyte Technologies Inc.
Empowering cell research by providing next-generation cell isolation technology.
Insporos
Analyzing greenhouse seeds to maximize efficiency and optimize yield.
Minpraxis Solutions Ltd.
Doubling the value of rock, generating orebody knowledge for productivity.
phaseLab
Providing error mitigation strategies for MRI and Quantum Computing.
Resolve Nanotherapeutics
Developing novel therapeutics for acute infections including pneumonia and sepsis.
Rock Reactor
Producing carbon-negative silica for industrial manufacturers to operate sustainably.
TruMotion Technologies Ltd.
Providing you with motion, comfort, and independence.
Tydra Labs
Transforming seafood waste into high-value, sustainable materials using biotechnology.
Xpress Select
Streamlining pharmacy care through smart, patient-facing technology.
Nanozen Industries Inc.
Providing API detection in real time to pharmaceutical customers to prevent delay in production.
UVX Inc.
Reducing infections, starting with hospitals.
Incisive Genetics
Developing an innovative lipid nanoparticle (LNP) delivery platform for genetic therapies.
These ventures represent the energy, creativity, and commercial potential emerging from UBC’s deep research and innovation ecosystem. From tackling global healthcare challenges to building smarter, greener materials, each company is seeking partners, investors, and champions to help accelerate their growth.
For more information or to register to attend, visit innovation.ubc.ca/2025-investor-showcase.
Reply